BTIG's double upgrade is a positive signal but tempered by a below-consensus target and mixed EPS revisions. Traders should view this as a modest bullish catalyst, not a game-changer — the stock's 32% upside to the mean target suggests room to run, but wait for confirmation from insider buying or institutional flows before adding size.
Price Chart
Executive Summary
BTIG double-upgraded Medtronic plc (MDT) from Neutral to Buy on June 4, 2026, setting a $90 price target. The call is contrarian relative to the consensus, where 21 of 37 analysts rate MDT a Buy or Strong Buy, 15 Hold, and 1 Sell. The mean price target is $103.15, implying 32.3% upside from the current $77.95, while BTIG's $90 target sits 12.7% below the mean. BTIG has a 53% accuracy rate on 948 calls with a 3.7% average return, placing it near the middle of the 14 firms tracked. The upgrade comes amid a quiet 30-day period with only 1 upgrade and 0 downgrades, and EPS revisions are mixed — 3 up and 3 down for the current quarter, but 5 down for the next quarter. No insider trades or institutional changes are reported, and a single congressional sell by Rep. Kevin Hern ($15k-$50k) is a weak signal. The double upgrade from a mid-tier firm with a below-consensus target warrants a modest positive adjustment.
Impact Score
Consensus & Targets
Of 37 analysts covering MDT, 8 rate it Strong Buy (21.6%), 13 Buy (35.1%), 15 Hold (40.5%), 1 Sell (2.7%), and 0 Strong Sell. The consensus is moderately bullish with 56.8% Buy-equivalent ratings, but a large 40.5% hold camp shows lingering caution.
Current price is $77.95. Mean target is $103.15 (32.3% upside), median $104 (33.4% upside), high $121 (55.2% upside), low $80 (2.6% upside). BTIG's $90 target is 12.7% below the mean and 13.5% below the median, making it one of the more conservative bullish calls.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-04 | Baird | maintain | Neutral | $85.00 |
| 2026-06-04 | BTIG | upgrade | Buy | $90.00 |
| 2026-06-03 | Mizuho | maintain | Outperform | $100.00 |
| 2026-06-03 | Needham | maintain | Buy | $101.00 |
| 2026-04-22 | UBS | maintain | Neutral | $90.00 |
| 2026-04-15 | Truist Securities | maintain | Hold | $95.00 |
| 2026-04-13 | Mizuho | maintain | Outperform | $120.00 |
| 2026-04-09 | Evercore ISI Group | maintain | Outperform | $106.00 |
| 2026-04-07 | Citigroup | maintain | Buy | $110.00 |
| 2026-04-06 | Evercore ISI Group | maintain | Outperform | $108.00 |
In the past 30 days, there has been 1 upgrade (BTIG) and 0 downgrades. EPS revisions are mixed: current quarter has 3 up and 3 down revisions over 30 days, but next quarter has 1 up and 5 down. Full-year estimates show 0 up and 5 down revisions, indicating downward pressure on forward expectations.
Firm Track Record — BTIG
BTIG accuracy: 53% on 948 calls | avg return: 3.7%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 14 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Mizuho | 100% | 2/2 | 11.1% | top tier |
| Bernstein | 100% | 2/2 | 6.4% | top tier |
| Needham | 75% | 9/12 | 4.1% | top tier |
| Baird | 71% | 5/7 | 4.8% | top tier |
| Citigroup | 67% | 4/6 | 3.5% | top tier |
| UBS | 67% | 4/6 | 4.1% | top tier |
| Wells Fargo | 60% | 3/5 | 3.3% | above average |
| Truist Securities | 60% | 6/10 | 4.8% | above average |
| RBC Capital | 56% | 5/9 | 3% | above average |
| Goldman Sachs | 50% | 1/2 | 4.4% | below average |
BTIG has a 53% accuracy rate on 948 calls with a 3.7% average return, ranking near the middle of the 14 firms tracked. Top-tier firms include Mizuho (100% on 2 calls, 11.1% avg return) and Bernstein (100% on 2 calls, 6.4% avg return). Bottom-tier firms include Barclays (33% on 3 calls, 1.3% avg return) and Stifel (33% on 3 calls, 1.8% avg return).
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $1.39 | $1.38 — $1.43 | $9.5B | ↑1 ↓0 |
| +1q | $1.38 | $1.32 — $1.46 | $9.5B | ↑1 ↓0 |
| 0y | $6.06 | $5.92 — $6.41 | $38.9B | ↑0 ↓0 |
| +1y | $6.48 | $6.15 — $7.10 | $39.9B | ↑0 ↓0 |
Cross-Platform Signals
No insider trades or institutional position changes are reported. A single congressional sell by Rep. Kevin Hern ($15k-$50k on March 20) is a weak bearish signal with no predictive power. Short interest data is unavailable. The analyst upgrade is not corroborated by insider buying or institutional accumulation, reducing its conviction level.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | Press Release | $92.60 $89.30 | ▼ −3.56% | ▼ −6.13% | $86.35 (−6.75%) |
Sep 15, 2026 16d ago | 425 | $92.60 $89.30 | ▼ −3.56% | ▼ −6.13% | $86.35 (−6.75%) |
Sep 14, 2026 17d ago | 425 | $93.75 $90.77 | ▼ −3.18% | ▼ −5.29% | $86.35 (−7.90%) |
Sep 14, 2026 18d ago | 425 | $93.80 $91.75 | ▼ −2.19% | ▼ −2.29% | $86.35 (−7.95%) |
Sep 14, 2026 18d ago | 425 | $93.80 $91.75 | ▼ −2.19% | ▼ −2.29% | $86.35 (−7.95%) |
Sep 1, 2026 4w ago | Press Release | $92.03 $91.89 | ▼ −0.15% | ▼ −0.23% | $86.35 (−6.18%) |
Sep 1, 2026 4w ago | 8-K | $92.04 $91.89 | ▼ −0.16% | ▼ −0.24% | $86.35 (−6.19%) |
Sep 1, 2026 4w ago | Press Release | $92.04 $91.89 | ▼ −0.16% | ▼ −0.24% | $86.35 (−6.19%) |
Aug 31, 2026 4w ago | Court Ruling | $90.65 $92.39 | ▲ +1.92% | ▲ +2.06% | $86.35 (−4.75%) |
Aug 20, 2026 6w ago | Press Release | $93.35 $91.15 | ▼ −2.36% | ▼ −2.83% | $86.35 (−7.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access